TriSalus Life Sciences, Inc. (TLSI)
4.97
-0.17
(-3.31%)
USD |
NASDAQ |
Sep 03, 15:33
TriSalus Life Sciences Total Assets (Quarterly) : 62.45M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 62.45M |
| March 31, 2026 | 70.98M |
| December 31, 2025 | 35.33M |
| September 30, 2025 | 36.46M |
| June 30, 2025 | 41.32M |
| March 31, 2025 | 28.62M |
| December 31, 2024 | 23.97M |
| September 30, 2024 | 27.48M |
| June 30, 2024 | 32.43M |
| March 31, 2024 | 17.89M |
| December 31, 2023 | 24.60M |
| September 30, 2023 | 33.55M |
| Date | Value |
|---|---|
| June 30, 2023 | 12.24M |
| March 31, 2023 | 20.52M |
| December 31, 2022 | 22.00M |
| September 30, 2022 | 251.33M |
| June 30, 2022 | 250.55M |
| March 31, 2022 | 250.40M |
| December 31, 2021 | 250.53M |
| September 30, 2021 | 250.76M |
| June 30, 2021 | 251.21M |
| March 31, 2021 | 251.79M |
| December 31, 2020 | |
| September 30, 2020 | 0.0675M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.90M |
| Shareholders Equity (Quarterly) | 6.55M |
| Debt to Equity Ratio | 5.256 |
| Current Ratio | 5.348 |
| Net Debt Paydown Yield | -0.09% |